3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
10
Colorectal Neoplasms
5
Stomach Neoplasms
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Biliary Tract Neoplasms
3
Sarcoma, Ewing
2
Recurrence
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Wilms Tumor
1
Small Cell Lung Carcinoma
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Metastatic Gastric Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Malignant Ascites
1
Hepatoblastoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
Gemcitabine
11
Cisplatin
10
pembrolizumab
5
Oxaliplatin
4
durvalumab
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Fluorouracil
3
tivozanib
2
Specimen Handling
2
Capecitabine
2
zimberelimab
1
trametinib
1
tislelizumab
1
quemliclustat
1
pertuzumab
1
olaparib
1
irinotecan sucrosofate
1
atezolizumab
1
anlotinib
1
Yttrium-90
1
Tissue Adhesives
1
Tegafur
1
Stents
1
S 1 (combination)
1
Ritonavir
1
Radiosurgery
1
Pancreaticojejunostomy
1
Pancreaticoduodenectomy
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bile Duct Neoplasms
×
irinotecan sucrosofate
×
1 year
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled